Back to Search
WALTER RAYFORD, M.D., PHD., FACS
M.D., PHD., FACS
Urology Physician
NPI: 1821103151IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
40580(TN)19176(MS)
CMS Specialties
PrimaryUROLOGY
Education
UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Class of 1991
Research & Publications (20)
Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.
PMID 19637357·Cancer·2009
8-other
Personality predicts prostate cancer treatment decision-making difficulty and satisfaction.
PMID 18821530·Psychooncology·2009
8-other
How to engage the Latino or African American patient with benign prostatic hyperplasia: crossing socioeconomic and cultural barriers.
PMID 18675612·Am J Med·2008
6-review
Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.
PMID 18268528·Prostate Cancer Prostatic Dis·2008
4-observational
Racial differences in pathogenetic mechanisms, prevalence, and progression of benign prostatic hyperplasia.
PMID 17113881·Urology·2006
6-review
Managing the low-socioeconomic-status prostate cancer patient.
PMID 16623064·J Natl Med Assoc·2006
6-review
Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer.
PMID 16581345·J Lab Clin Med·2006
8-other
Prostate specific antigen isoforms and human glandular kallikrein 2--which offers the best screening performance in a predominantly black population?
PMID 16406882·J Urol·2006
8-other
Knowledge, attitudes and beliefs of women about the importance of prostate cancer screening.
PMID 16353659·J Natl Med Assoc·2005
8-other
Sicklepod (Senna obtusifolia) seed processing and potential utilization.
PMID 15941316·J Agric Food Chem·2005
8-other
Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells.
PMID 15897971·Asian J Androl·2005
8-other
The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management.
PMID 15638887·BJU Int·2005
6-review
TNF receptor 1 is involved in the induction of apoptosis by the cyclin dependent kinase inhibitor p27Kip1 in the prostate cancer cell line PC-3.
PMID 15545300·FASEB J·2005
8-other
Increased levels of serum transferrin receptor and serum transferrin receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores.
PMID 15514585·J Lab Clin Med·2004
8-other
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
PMID 15371828·J Urol·2004
3-trial
Establishment and characterization of a primary androgen-responsive African-American prostate cancer cell line, E006AA.
PMID 15162380·Prostate·2004
7-preclinical
Serum ferritin levels and transferrin saturation in men with prostate cancer.
PMID 15160979·J Natl Med Assoc·2004
4-observational
Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA).
PMID 15007379·Prostate Cancer Prostatic Dis·2004
4-observational
Gene expression profiling identifies clinically relevant subtypes of prostate cancer.
PMID 14711987·Proc Natl Acad Sci U S A·2004
8-other
Complexed PSA performance for prostate cancer detection in an African-American population.
PMID 14624904·Urology·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6029 WALNUT GROVE RD., SUITE 300
MEMPHIS, TN 38120 - Phone
- (901) 767-8158
Quick Facts
- NPI
- 1821103151
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile